(NASDAQ: TYRA) Tyra Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.36%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 31.22%.
Tyra Biosciences's earnings in 2026 is -$148,565,000.On average, 17 Wall Street analysts forecast TYRA's earnings for 2026 to be -$163,479,007, with the lowest TYRA earnings forecast at -$167,262,525, and the highest TYRA earnings forecast at -$137,853,729. On average, 17 Wall Street analysts forecast TYRA's earnings for 2027 to be -$179,782,746, with the lowest TYRA earnings forecast at -$196,504,225, and the highest TYRA earnings forecast at -$141,613,376.
In 2028, TYRA is forecast to generate -$197,715,667 in earnings, with the lowest earnings forecast at -$236,857,771 and the highest earnings forecast at -$84,592,061.